Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case–control studyDaniela Massi, Marco Santucci, Gianna Baroni et al.|Journal of Clinical Pathology|2006Cited by 120
BO-112 Plus Pembrolizumab for Patients With Anti–PD-1–Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203Iván Márquez‐Rodas, Stéphane Dalle, Caroline Dutriaux et al.|Journal of Clinical Oncology|2025Cited by 7
HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung CancerMaría González‐Cao, Rafael Rosell|Lung Cancer Targets and Therapy|2024Cited by 5